Hui Cheng

558 total citations
14 papers, 419 citations indexed

About

Hui Cheng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hui Cheng has authored 14 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hui Cheng's work include Cancer-related molecular mechanisms research (7 papers), Cancer, Lipids, and Metabolism (4 papers) and Ferroptosis and cancer prognosis (4 papers). Hui Cheng is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Cancer, Lipids, and Metabolism (4 papers) and Ferroptosis and cancer prognosis (4 papers). Hui Cheng collaborates with scholars based in China. Hui Cheng's co-authors include Jingjing Su, Qinglin Li, Jun Chu, Ting Jiang, Xuncui Wang, Meng Wang, Youlin Wang, Yueyue Li, Long Jiao and Yu Cao and has published in prestigious journals such as Journal of Ethnopharmacology, Toxicology and Applied Pharmacology and BioMed Research International.

In The Last Decade

Hui Cheng

13 papers receiving 415 citations

Peers

Hui Cheng
Hui Cheng
Citations per year, relative to Hui Cheng Hui Cheng (= 1×) peers Xiaotian Xu

Countries citing papers authored by Hui Cheng

Since Specialization
Citations

This map shows the geographic impact of Hui Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Cheng more than expected).

Fields of papers citing papers by Hui Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Cheng. The network helps show where Hui Cheng may publish in the future.

Co-authorship network of co-authors of Hui Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Cheng. A scholar is included among the top collaborators of Hui Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Cheng. Hui Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Li, Lijie, et al.. (2025). ARRB2 promotes cervical cancer progression via stabilizing CDC25A mRNA through m6A-IGF2BP1-dependent manner. npj Precision Oncology. 9(1). 80–80. 1 indexed citations
3.
Zhou, Wenxian, Hui Cheng, Chia‐Kwung Fan, et al.. (2025). LAMP3-mediated epithelial-mesenchymal transition promotes the invasion and excessive proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Journal of Autoimmunity. 151. 103359–103359. 4 indexed citations
4.
Yang, Yuting, Chun Liu, Hui Cheng, et al.. (2024). Arenobufagin regulates the p62-Keap1-Nrf2 pathway to induce autophagy-dependent ferroptosis in HepG2 cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(7). 4895–4909. 9 indexed citations
5.
Jiao, Long, Wenjun Wang, Meng Wang, et al.. (2024). Overexpression of Nrf2 reverses ferroptosis induced by Arenobufagin in gastric cancer. Toxicology and Applied Pharmacology. 484. 116842–116842. 6 indexed citations
6.
Li, Yueyue, Cheng Zhao, Yuting Yang, et al.. (2024). Arenobufagin modulation of PCSK9-mediated cholesterol metabolism induces tumor-associated macrophages polarisation to inhibit hepatocellular carcinoma progression. Phytomedicine. 128. 155532–155532. 13 indexed citations
7.
Wang, Meng, Yueyue Li, Shanshan Li, et al.. (2023). Cinobufacini injection delays hepatocellular carcinoma progression by regulating lipid metabolism via SREBP1 signaling pathway and affecting macrophage polarization. Journal of Ethnopharmacology. 321. 117472–117472. 10 indexed citations
8.
Wang, Meng, Yating Tu, Chun Liu, et al.. (2023). Gambogenic Acid Inhibits Invasion and Metastasis of Melanoma through Regulation of lncRNA MEG3. Biological and Pharmaceutical Bulletin. 46(10). 1385–1393. 9 indexed citations
9.
Wang, Meng, Hui Cheng, Huan Wu, et al.. (2022). Gambogenic acid antagonizes the expression and effects of long non-coding RNA NEAT1 and triggers autophagy and ferroptosis in melanoma. Biomedicine & Pharmacotherapy. 154. 113636–113636. 36 indexed citations
10.
Cheng, Hui, Meng Wang, Jingjing Su, et al.. (2022). Lipid Metabolism and Cancer. Life. 12(6). 784–784. 59 indexed citations
11.
Chen, Cheng, et al.. (2021). Development and Validation of a Novel Ferroptosis‐Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer. BioMed Research International. 2021(1). 6014202–6014202. 12 indexed citations
12.
Wang, Meng, et al.. (2020). Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition. Toxicology and Applied Pharmacology. 401. 115110–115110. 69 indexed citations
13.
Jiang, Ting, Jun Chu, Hui Cheng, et al.. (2020). Gastrodin Inhibits H<sub>2</sub>O<sub>2</sub>-Induced Ferroptosis through Its Antioxidative Effect in Rat Glioma Cell Line C6. Biological and Pharmaceutical Bulletin. 43(3). 480–487. 55 indexed citations
14.
Jiang, Ting, Hui Cheng, Jingjing Su, et al.. (2019). Gastrodin protects against glutamate-induced ferroptosis in HT-22 cells through Nrf2/HO-1 signaling pathway. Toxicology in Vitro. 62. 104715–104715. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026